New York, USA and Bangalore, India – March 15, 2022: Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced that that it has been positioned as a ‘Leader’ in the Everest Group PEAK Matrix® for Intelligent Automation in Healthcare Solutions Provider 2022 report.
The report recognized Wipro’s key strengths as its “ecosystem of strategic alliances and partnerships, increased capabilities under Revenue Cycle Management (RCM), proactiveness, ideation capability and collaboration.” The report also noted that more than 50% of Wipro’s clients have deployed 25 or more bots in outcome/output-based contracts that are driven by Wipro’s Digital Academy – a team that delivers dynamic and innovative automation services on the fly.
“Intelligent automation has long been a priority for healthcare organizations, but the pandemic has dramatically increased the need to reimagine and re-transform healthcare operations using data and process intelligence across large transformation projects,” said Mohd Haque, Senior Vice President & Sector Head, Healthcare & Medical Devices, Wipro Limited. “By applying Wipro’s domain expertise and the advanced, augmented intelligence capabilities of Wipro Holmes, healthcare organizations can unlock value faster, accelerate their transformation across the value chain, and become more data-driven intelligent enterprises.”
“The disruption in the healthcare industry caused by COVID-19 accelerated the adoption of new-gen technologies, such as AI-driven automation exponentially, as enterprises suffered revenue and branding losses,” said Ankur Verma, Practice Director, Healthcare and Life Sciences Practice, Everest Group. “The post-pandemic priorities of buyers have centered around newer innovations; intelligent automation being a focal point among tech-innovations. Wipro with its strategic alliances and key partnerships with leading third-party technology vendors has helped it mark itself as a strong player in this area. Its persistent focus on increasing bot scalability, nurturing digital talent through initiatives such as Digital Academy, and push toward output/outcome-based impact has placed it as one of the Leaders on Everest Group’s Intelligent Automation in Healthcare – Solutions PEAK Matrix® Assessment 2022.”
The report classified 18 healthcare service providers based on their current market impact, vision and capability in employing automation solutions such as cloud, Robotic Process Automation, Natural Language Processing, Artificial Intelligence/Machine Learning and more with existing healthcare functions across the payor and provider value chain. The study was based on responses from service providers, interactions with their leadership, client reference checks and an ongoing analysis of the engineering services market.
Wipro’s Healthcare and Medical Devices Services helps payor, provider and medical device companies upgrade themselves and cater to the growing demand for value-based care to patients around the world.
About Wipro Limited
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) is a leading global information technology, consulting and business process services company. We harness the power of cognitive computing, hyper-automation, robotics, cloud, analytics, and emerging technologies to help our clients adapt to the digital world and make them successful. A company recognized globally for its comprehensive portfolio of services, strong commitment to sustainability and good corporate citizenship, we have over 220,000 dedicated employees serving clients across six continents. Together, we discover ideas and connect the dots to build a better and a bold new future.
Media Contact:
Nisha Chandrasekaran
Wipro Limited
nisha.chandrasekaran@wipro.com
Forward-Looking Statements
The forward-looking statements contained herein represent Wipro’s beliefs regarding future events, many of which are by their nature, inherently uncertain and outside Wipro’s control. Such statements include, but are not limited to, statements regarding Wipro’s growth prospects, its future financial operating results, and its plans, expectations and intentions. Wipro cautions readers that the forward-looking statements contained herein are subject to risks and uncertainties that could cause actual results to differ materially from the results anticipated by such statements. Such risks and uncertainties include, but are not limited to, risks and uncertainties regarding fluctuations in our earnings, revenue and profits, our ability to generate and manage growth, complete proposed corporate actions, intense competition in IT services, our ability to maintain our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which we make strategic investments, withdrawal of fiscal governmental incentives, political instability, war, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property and general economic conditions affecting our business and industry. The conditions caused by the COVID-19 pandemic could decrease technology spending, adversely affect demand for our products, affect the rate of customer spending and could adversely affect our customers’ ability or willingness to purchase our offerings, delay prospective customers’ purchasing decisions, adversely impact our ability to provide on-site consulting services and our inability to deliver our customers or delay the provisioning of our offerings, all of which could adversely affect our future sales, operating results and overall financial performance. Our operations may also be negatively affected by a range of external factors related to the COVID-19 pandemic that are not within our control. Additional risks that could affect our future operating results are more fully described in our filings with the United States Securities and Exchange Commission, including, but not limited to, Annual Reports on Form 20-F. These filings are available at www.sec.gov. We may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statement that may be made from time to time by us or on our behalf.
